Sort
82,697 grants matching “vaccine development”
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomicsâ reduced genome E. coli strains
$877,755Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2017 · AI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
$877,748Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2021 · AI
ATECAR: Asian Training, Education on Cancer & Research
$877,547Grace X Ma · Temple Univ Of The Commonwealth · U01 · FY2007 · CA
KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection
$877,449Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2021 · AI
Identification and validation of influenza host factors as therapeutic targets
$877,411David E Root · Broad Institute, Inc. · U01 · FY2010 · AI
Core A - Administrative Core
$877,384James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2024 · AI
Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers
$877,375D. Noah Sather · Seattle Children'S Hospital · R01 · FY2022 · AI
A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection
$877,357John A Moss · Oak Crest Institute Of Science · R01 · FY2021 · AI
Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.
$877,087Cynthia Ann Derdeyn · Emory University · R01 · FY2021 · AI
Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2
$876,907Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2022 · AI
Collaborative Research: Ideas Lab: The Role of Extracellular RNA in Intercellular and Interkingdom Communication
$876,898Patricia Baldrich · University Of California-Davis · · FY2024 · BIO
MICROCHIP DRUG DELIVERY SYSTEM
$876,887Massachusetts Institute Of Technology · R24 · FY2000 · AI
Basic Research Support for the CCR
$876,849Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Technologies for Human Cellular Immunology
$876,837Lawrence J Stern · Univ Of Massachusetts Med Sch Worcester · U19 · FY2008 · AI
Cross-Protective Multivalent Vaccine for Tick-Borne Flaviviruses
$876,712David E. Clements · Hawaii Biotech, Inc. · R44 · FY2021 · AI
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
$876,592Roger Keith Reeves · Beth Israel Deaconess Medical Center · R01 · FY2017 · AI
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
$876,592Roger Keith Reeves · Beth Israel Deaconess Medical Center · R01 · FY2019 · AI
T. vaginalis viruses as mucosal immunity modifiers with impact on women's health
$876,546Raina N Fichorova · Brigham And Women'S Hospital · R56 · FY2012 · AI
Chemoprophylaxis and HIV-Host Interactions
$876,529Robert M. Grant · J. David Gladstone Institutes · R01 · FY2011 · AI
Tuning Fc-effector functions of HIV-specific antibodies
$876,355Galit Alter · Massachusetts General Hospital · R01 · FY2015 · AI
Analysis and Modulation of Virus-Host Interaction in Infections of the Liver
$876,128Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Task A16 Neisseria gonorrhoeae mouse infection model
$876,070 · N01 · FY2010 · AI
NORTH CAROLINA STD COOPERATIVE RESEARCH CENTER
$875,995University Of North Carolina Chapel Hill · U19 · FY2003 · AI
Systems Biology Approaches to Viral Pathogenesis and Immunity
$875,992Michael G Katze · Oregon Health & Science University · U54 · FY2013 · AI
JAK-STAT Control of Zika Virus-Induced Fetal Injury
$875,928Kristina M Adams Waldorf · University Of Washington · R01 · FY2020 · AI